Related Experiment Video
Updated: Jun 28, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Clinical characteristics and outcomes of venous thromboembolism in patients hospitalized for COVID-19: Systematic
Joshua Henrina1, Iwan Cahyo Santosa Putra1, Irvan Cahyadi1
1Siloam Heart Institute, Jakarta, Indonesia.
Hospitalized COVID-19 patients with venous thromboembolism (VTE) showed no difference in mortality. However, VTE was linked to increased ICU admission, mechanical ventilation, and specific laboratory abnormalities, aiding risk stratification.
Area of Science:
- * Medical Research
- * Infectious Diseases
- * Cardiovascular Medicine
Background:
- * Venous thromboembolism (VTE) is a significant complication in hospitalized patients with COVID-19.
- * Understanding the clinical characteristics and outcomes associated with VTE in this population is crucial for patient management.
Purpose of the Study:
- * To systematically review and meta-analyze the differences in clinical characteristics and outcomes between hospitalized COVID-19 patients with and without VTE.
- * To identify factors associated with VTE in COVID-19 patients.
Main Methods:
- * Systematic review and meta-analysis of 45 studies for qualitative synthesis and 38 studies for quantitative analysis.
- * Inclusion of 8859 patients for qualitative synthesis and 7847 patients for quantitative analysis.
- * Comparison of clinical characteristics, laboratory values, and outcomes between VTE-positive and VTE-negative groups.
Main Results:
- * No significant difference in mortality between COVID-19 patients with and without VTE (RR 1.32).
- * VTE (+) patients had higher rates of intensive care unit admission (RR 1.77) and mechanical ventilation (RR 2.35).
- * Male gender, elevated white blood cell count, D-Dimer, ALT, LDH, CRP, and prolonged prothrombin time were associated with VTE; lower albumin and NLR were also observed.
Conclusions:
- * While VTE does not increase mortality in hospitalized COVID-19 patients, it is associated with more severe disease requiring intensive care.
- * Specific clinical and laboratory markers can help identify COVID-19 patients at higher risk for VTE.
- * Findings provide a framework for risk stratification of hospitalized COVID-19 patients for VTE.
More Related Videos
Related Concept Videos
Pneumonia III: Complications and Assessment
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

